Hyperinsulinaemia in cancer

Harmonizing the Metabolic Syndrome: A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity

Alberti, K. G. M. M., Eckel, R. H., Grundy, S. M., Zimmet, P. Z., Cleeman, J. I., Donato, K. A., Fruchart, J.-C., James, W. P. T., Loria, C. M., & Smith, S. C. (2009) · Circulation · doi:10.1161/circulationaha.109.192644 · Cited by 14,860

Role of Insulin Resistance in Human Disease

Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154

Use and Abuse of HOMA Modeling

Wallace, T. M., Levy, J. C., & Matthews, D. R. (2004) · Diabetes Care · doi:10.2337/diacare.27.6.1487 · Cited by 5,114

Body Fatness and Cancer — Viewpoint of the IARC Working Group

Lauby-Secretan, B., Scoccianti, C., Loomis, D., Grosse, Y., Bianchini, F., & Straif, K. (2016) · New England Journal of Medicine · doi:10.1056/nejmsr1606602 · Cited by 3,596

The Effect of Diet on the Human Gut Microbiome: A Metagenomic Analysis in Humanized Gnotobiotic Mice

Turnbaugh, P. J., Ridaura, V. K., Faith, J. J., Rey, F. E., Knight, R., & Gordon, J. I. (2009) · Science Translational Medicine · doi:10.1126/scitranslmed.3000322 · Cited by 3,058

Definition and diagnostic criteria of clinical obesity

Rubino, F., Cummings, D. E., Eckel, R. H., Cohen, R. V., Wilding, J. P. H., Brown, W. A., Stanford, F. C., Batterham, R. L., Farooqi, I. S., Farpour-Lambert, N. J., et al. (2025) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(24)00316-4 · Cited by 1,811

Metabolomics in cancer research and emerging applications in clinical oncology

Schmidt, D. R., Patel, R., Kirsch, D. G., Lewis, C. A., Heiden, M. G. V., & Locasale, J. W. (2021) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21670 · Cited by 675

Tumor initiation and early tumorigenesis: molecular mechanisms and interventional targets

Zhang, S., Xiao, X., Yi, Y., Wang, X., Zhu, L., Shen, Y., Lin, D., & Wu, C. H. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01848-7 · Cited by 463

Tumour fatty acid metabolism in the context of therapy resistance and obesity

Hoy, A. J., Nagarajan, S. R., & Butler, L. M. (2021) · Nature reviews. Cancer · doi:10.1038/s41568-021-00388-4 · Cited by 415

Hyperinsulinemia in Obesity, Inflammation, and Cancer

Zhang, A. M. Y., Wellberg, E. A., Kopp, J. L., & Johnson, J. D. (2021) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2020.0250 · Cited by 344

Hyperinsulinemia and Its Pivotal Role in Aging, Obesity, Type 2 Diabetes, Cardiovascular Disease and Cancer

Janssen, J. A. M. J. L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22157797 · Cited by 315

Obesity, Type 2 Diabetes, and Cancer Risk

Scully, T., Ettela, A., LeRoith, D., & Gallagher, E. J. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2020.615375 · Cited by 289

Adipokines: masterminds of metabolic inflammation

Tilg, H., Ianiro, G., Gasbarrini, A., & Adolph, T. E. (2024) · Nature reviews. Immunology · doi:10.1038/s41577-024-01103-8 · Cited by 234

Metabolically healthy obesity: from epidemiology and mechanisms to clinical implications

Schulze, M. B., & Stefan, N. (2024) · Nature Reviews Endocrinology · doi:10.1038/s41574-024-01008-5 · Cited by 211

Insulin Resistance and Cancer: In Search for a Causal Link

CHIEFARI, E. D., Mirabelli, M., Vignera, S. L., Tanyolaç, S., FOTI, D. P., Aversa, A., & Brunetti, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222011137 · Cited by 180

Developing dietary interventions as therapy for cancer

Taylor, S. R., Falcone, J. N., Cantley, L. C., & Goncalves, M. D. (2022) · Nature reviews. Cancer · doi:10.1038/s41568-022-00485-y · Cited by 168

An overview of cancer health disparities: new approaches and insights and why they matter

Minas, T. Z., Bailey‐Whyte, M., Ajao, A., & Ambs, S. (2020) · Carcinogenesis · doi:10.1093/carcin/bgaa121 · Cited by 119

Distinct signaling by insulin and IGF-1 receptors and their extra- and intracellular domains

Nagao, H., Cai, W., Albrechtsen, N. J. W., Steger, M., Batista, T. M., Pan, H., Dreyfuss, J. M., Mann, M., & Kahn, C. R. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2019474118 · Cited by 114

Metabolic dysfunction-associated steatotic liver disease and its link to cancer

Kalligeros, M., Henry, L. L., & Younossi, Z. M. (2024) · Metabolism · doi:10.1016/j.metabol.2024.156004 · Cited by 115

Insulin Resistance: The Increased Risk of Cancers

Szablewski, L. (2024) · Current Oncology · doi:10.3390/curroncol31020075 · Cited by 123

Associations Between Glycemic Traits and Colorectal Cancer: A Mendelian Randomization Analysis

Murphy, N., Song, M., Papadimitriou, N., Carreras‐Torres, R., Langenberg, C., Martin, R. M., Tsilidis, K. K., Barroso, I., Chen, J., Frayling, T. M., et al. (2022) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djac011 · Cited by 103

Regulation and function of insulin and insulin-like growth factor receptor signalling

Choi, E., Duan, C., & Bai, X. (2025) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-025-00826-3 · Cited by 102

Hyperinsulinemia acts via acinar insulin receptors to initiate pancreatic cancer by increasing digestive enzyme production and inflammation

Zhang, A. M. Y., Xia, Y. H., Lin, J. S. H., Chu, K., Wang, W. C. K., Ruiter, T. J. J., Yang, J. C. C., Chen, N., Chhuor, J., Patil, S., et al. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2023.10.003 · Cited by 91

Insulin and cancer: a tangled web

Leitner, B. P., Siebel, S., Akingbesote, N. D., Zhang, X., & Perry, R. J. (2022) · Biochemical Journal · doi:10.1042/bcj20210134 · Cited by 79

Obesity: a perfect storm for carcinogenesis

Harris, B. H. L., Macaulay, V. M., Harris, D. A., Klenerman, P., Karpe, F., Lord, S., Harris, A. L., & Buffa, F. M. (2022) · Cancer and Metastasis Reviews · doi:10.1007/s10555-022-10046-2 · Cited by 84

Cellular mechanisms linking cancers to obesity

Liu, X., Pedersen, L., & Halberg, N. (2021) · Cell Stress · doi:10.15698/cst2021.05.248 · Cited by 74

Diversity of insulin and IGF signaling in breast cancer: Implications for therapy

Lero, M. W., & Shaw, L. M. (2021) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2021.111213 · Cited by 71

Value of C-Reactive Protein-Triglyceride Glucose Index in Predicting Cancer Mortality in the General Population: Results from National Health and Nutrition Examination Survey

Zhao, D. (2023) · Nutrition and Cancer · doi:10.1080/01635581.2023.2273577 · Cited by 71

Obesity and Breast Cancer Risk: The Oncogenic Implications of Metabolic Dysregulation

Naaman, S., Shen, S., Zeytinoglu, M., & Iyengar, N. M. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac241 · Cited by 71

Risk of thyroid cancer associated with glucagon‐like peptide‐1 receptor agonists and dipeptidyl peptidase‐4 inhibitors in patients with type 2 diabetes: A population‐based cohort study

Bea, S., Son, H., Bae, J. H., Cho, S. W., Shin, J., & Cho, Y. M. (2024) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.15292 · Cited by 64

Endothelial insulin resistance induced by adrenomedullin mediates obesity-associated diabetes

Cho, H., Lai, C.-C., Bonnavion, R., Alnouri, M. W., Wang, S., Roquid, K. A., Kawase, H., Campos, D., Chen, M., Weinstein, L. S., et al. (2025) · Science · doi:10.1126/science.adr4731 · Cited by 69

Obesity-induced changes in cancer cells and their microenvironment: Mechanisms and therapeutic perspectives to manage dysregulated lipid metabolism

Lee‐Rueckert, M., Canyelles, M., Tondo, M., Rotllán, N., Kovanen, P. T., Llorente‐Cortés, V., & Escolá‐Gil, J. C. (2023) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2023.05.002 · Cited by 68

Fructose‐1,6‐Bisphosphate Aldolase B Depletion Promotes Hepatocellular Carcinogenesis Through Activating Insulin Receptor Signaling and Lipogenesis

Liu, G., Wang, N., Zhang, C., Li, M., He, X., Yin, C., Tu, Q., Shen, X., Zhang, L., Lv, J., et al. (2021) · Hepatology · doi:10.1002/hep.32064 · Cited by 61

Changes in Cells Associated with Insulin Resistance

Szablewski, L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25042397 · Cited by 78

Metabolic dysfunction and cancer in HCV: Shared pathways and mutual interactions

Leslie, J., Geh, D., Elsharkawy, A. M., Mann, D. A., & Vacca, M. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.01.029 · Cited by 61

Novel strategies for glycaemic control and preventing diabetic complications applying the clustering-based classification of adult-onset diabetes mellitus: A perspective

Tanabe, H., Masuzaki, H., & Shimabukuro, M. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.109067 · Cited by 61

Metabolic dependencies and targets in ovarian cancer

Zhang, Y., Wang, Y., Zhao, G., Oršulić, S., & Matei, D. E. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108413 · Cited by 65

Metabolic syndrome and the risk of colorectal cancer: a systematic review and meta-analysis

Shen, X., Wang, Y., Zhao, R., Wan, Q., Wu, Y., Zhao, L., & Wu, X. (2021) · International Journal of Colorectal Disease · doi:10.1007/s00384-021-03974-y · Cited by 60

The Relationship between Diabetes Mellitus and Gastric Cancer and the Potential Benefits of Metformin: An Extensive Review of the Literature

Tseng, C. (2021) · Biomolecules · doi:10.3390/biom11071022 · Cited by 55

Metabolic regulation of T cells in the tumor microenvironment by nutrient availability and diet

Zhao, S., Peralta, R. M., Avina-Ochoa, N., Delgoffe, G. M., & Kaech, S. M. (2021) · Seminars in Immunology · doi:10.1016/j.smim.2021.101485 · Cited by 58

Pancreatic endocrine and exocrine signaling and crosstalk in physiological and pathological status

Hu, C., Chen, Y., Yin, X., Xu, R., Yin, C., Wang, C., & Zhao, Y. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02098-3 · Cited by 69

Molecular mechanisms of action of metformin: latest advances and therapeutic implications

Zhu, H., Jia, Z., Li, Y. R., & Danelisen, I. (2023) · Clinical and Experimental Medicine · doi:10.1007/s10238-023-01051-y · Cited by 59

Pathogenesis of (smoking-related) non-communicable diseases—Evidence for a common underlying pathophysiological pattern

Kopp, W. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.1037750 · Cited by 60

A stepwise activation model for the insulin receptor

Yunn, N.-O., Kim, J., Ryu, S. H., & Cho, Y. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-01101-1 · Cited by 57

Diabetes, Antidiabetic Medications and Cancer Risk in Type 2 Diabetes: Focus on SGLT-2 Inhibitors

Dąbrowski, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041680 · Cited by 50

Characterization, management, and risk factors of hyperglycemia during PI3K or AKT inhibitor treatment

Liu, D., Weintraub, M. A., Garcia, C., Goncalves, M. D., Sisk, A. E., Casas, A., Harding, J. J., Harnicar, S. J., Drilon, A. E. D. C., Jhaveri, K. L., et al. (2022) · Cancer Medicine · doi:10.1002/cam4.4579 · Cited by 47

Critical material designs for mucus- and mucosa-penetrating oral insulin nanoparticle development

Zaiki, Y., Lim, L. Y., & Wong, T. W. (2022) · International Materials Reviews · doi:10.1080/09506608.2022.2040293 · Cited by 45

Integrative proteogenomic characterization reveals therapeutic targets in poorly differentiated and anaplastic thyroid cancers

Pan, Z., Tan, Z., Xu, N., Yao, Z., Zheng, C., Shang, J., Xie, L., Xu, J., Wang, J., Jiang, L., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-58910-3 · Cited by 47

Type 2 Diabetes Mellitus Intersects With Pancreatic Cancer Diagnosis and Development

Duan, X., Wang, W., Pan, Q., & Guo, L. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.730038 · Cited by 41

The insulin and IGF signaling pathway sustains breast cancer stem cells by IRS2/PI3K-mediated regulation of MYC

Lee, J., Lero, M. W., Mercado-Matos, J., Zhu, S., Jo, M., Tocheny, C. E., Morgan, J. S., & Shaw, L. M. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111759 · Cited by 40

Nutrition and dietary restrictions in cancer prevention

Mishra, A. K., Giuliani, G., & Longo, V. D. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.189063 · Cited by 38

The Interlinking Metabolic Association between Type 2 Diabetes Mellitus and Cancer: Molecular Mechanisms and Therapeutic Insights

Asiri, A., Qarni, A. A. A., & Bakillah, A. (2024) · Diagnostics · doi:10.3390/diagnostics14192132 · Cited by 37

Drug‐like sphingolipid SH‐BC‐893 opposes ceramide‐induced mitochondrial fission and corrects diet‐induced obesity

Jayashankar, V., Selwan, E. M., Hancock, S. E., Verlande, A., Goodson, M. O., Eckenstein, K. H., Milinkeviciute, G., Hoover, B., Chen, B., Fleischman, A. G., et al. (2021) · EMBO Molecular Medicine · doi:10.15252/emmm.202013086 · Cited by 31

Assessing the association of diabetes with lung cancer risk

Leiter, A., Charokopos, A., Bailey, S., Gallagher, E. J., Hirsch, F. R., LeRoith, D., & Wisnivesky, J. P. (2021) · Translational Lung Cancer Research · doi:10.21037/tlcr-21-601 · Cited by 31

Effects of hyperinsulinemia on pancreatic cancer development and the immune microenvironment revealed through single-cell transcriptomics

Zhang, A. M. Y., Chu, K., Daly, B. F., Ruiter, T. J. J., Dou, Y., Yang, J. C. C., de Winter, T. J. J., Chhuor, J., Wang, S., Flibotte, S., et al. (2022) · Cancer & Metabolism · doi:10.1186/s40170-022-00282-z · Cited by 32

Food processing groups and colorectal cancer risk in Morocco: evidence from a nationally representative case–control study

Kinany, K. E., Huybrechts, I., Hatime, Z., Asri, A. E., Boudouaya, H. A., Deoula, M. M. S., Kampman, E., & Rhazi, K. E. (2022) · European Journal of Nutrition · doi:10.1007/s00394-022-02820-3 · Cited by 30

Insulin resistance in cancer risk and prognosis

Jacobo-Tovar, E., Medel-Sánchez, A., Durán-Castillo, C., & Guardado‐Mendoza, R. (2025) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2025.06.006 · Cited by 33

Metabolic disorders sensitise endometrial carcinoma through endoplasmic reticulum stress

Zhou, J., Lin, Y., Yang, X., Shen, B., Hao, J., Wang, J., & Wang, J. (2022) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-022-00412-x · Cited by 29

Socioeconomic status and lifestyle patterns in the most common cancer types-community-based research

Sandström, N., Johansson, M., Jekunen, A. P., & Andersén, H. (2023) · BMC Public Health · doi:10.1186/s12889-023-16677-6 · Cited by 33

Unmasking BACE1 in aging and age-related diseases

Bao, H., & Shen, Y. (2022) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2022.11.008 · Cited by 28

Insulin resistance and cancer: molecular links and clinical perspectives

Caturano, A., Erul, E., Nilo, R., Nilo, D., Russo, V., Rinaldi, L., Acierno, C., Gemelli, M. T., Ricotta, R., Sasso, F. C., et al. (2025) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-025-05245-8 · Cited by 27

Moringa Oleifera Seed Extract Concomitantly Supplemented with Chemotherapy Worsens Tumor Progression in Mice with Triple Negative Breast Cancer and Obesity

Zunica, E. R. M., Yang, S., Coulter, A. A., White, C. L., Kirwan, J. P., & Gilmore, L. A. (2021) · Nutrients · doi:10.3390/nu13092923 · Cited by 26

A whole-food, plant-based randomized controlled trial in metastatic breast cancer: weight, cardiometabolic, and hormonal outcomes

Campbell, T. M., Campbell, E. K., Culakova, E., Blanchard, L., Wixom, N., Guido, J. J., Fetten, J. V., Huston, A. J., Shayne, M., Janelsins, M. C., et al. (2024) · Breast Cancer Research and Treatment · doi:10.1007/s10549-024-07266-1 · Cited by 26

mTORC1 and SGLT2 Inhibitors—A Therapeutic Perspective for Diabetic Cardiomyopathy

Saha, S., Fang, X., Green, C. D., & Das, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242015078 · Cited by 26

Novel Mechanisms of Tumor Promotion by the Insulin Receptor Isoform A in Triple-Negative Breast Cancer Cells

Vella, V., Giuliano, M., Ferlita, A. L., PELLEGRINO, M. A., Gaudenzi, G., Alaimo, S., Massimino, M., Pulvirenti, A., Dicitore, A., Vigneri, P. G., et al. (2021) · Cells · doi:10.3390/cells10113145 · Cited by 24

Growth Hormone Action as a Target in Cancer: Significance, Mechanisms, and Possible Therapies

Basu, R., Boguszewski, C. L., & Kopchick, J. J. (2024) · Endocrine Reviews · doi:10.1210/endrev/bnae030 · Cited by 26

Associations of metabolic syndrome and metabolically unhealthy obesity with cancer mortality: The Japan Multi-Institutional Collaborative Cohort (J-MICC) study

Tiến, N. V., Arisawa, K., Katsuura‐Kamano, S., Ishizu, M., Nagayoshi, M., Okada, R., Hishida, A., Tamura, T., Hara, M., Tanaka, K., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0269550 · Cited by 22

Impact of body-mass index on treatment and outcome in locally advanced rectal cancer: A secondary, post-hoc analysis of the CAO/ARO/AIO-04 randomized phase III trial

Diefenhardt, M., Ludmir, E. B., Hofheinz, R., Ghadimi, M. B., Minsky, B. D., Fleischmann, M., Fokas, E., & Rödel, C. M. (2021) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2021.09.028 · Cited by 21

VAPB-mediated ER-targeting stabilizes IRS-1 signalosomes to regulate insulin/IGF signaling

Gao, X. K., Sheng, Z. K., Lu, Y. H., Sun, Y. T., Rao, X. S., Shi, L. J., Cong, X. X., Chen, X., Wu, H. B., Huang, M., et al. (2023) · Cell Discovery · doi:10.1038/s41421-023-00576-6 · Cited by 20

Effects of Functional and Nutraceutical Foods in the Context of the Mediterranean Diet in Patients Diagnosed with Breast Cancer

Flore, G., Deledda, A., Lombardo, M., Armani, A., & Velluzzi, F. (2023) · Antioxidants · doi:10.3390/antiox12101845 · Cited by 24

Race as a Contributor to Stromal Modulation of Tumor Progression

Kakarla, M., ChallaSivaKanaka, S., Hayward, S. W., & Franco, O. E. (2021) · Cancers · doi:10.3390/cancers13112656 · Cited by 20

Glucose Enhances Pro-Tumorigenic Functions of Mammary Adipose-Derived Mesenchymal Stromal/Stem Cells on Breast Cancer Cell Lines

Ambrosio, M. R., Mosca, G., Migliaccio, T., Liguoro, D., Nele, G., Schönauer, F., D’Andrea, F., Liotti, F., Prevete, N., Melillo, R. M., et al. (2022) · Cancers · doi:10.3390/cancers14215421 · Cited by 18

Triglyceride-Glucose Index, Modifiable Lifestyle, and Risk of Colorectal Cancer: A Prospective Analysis of the Korean Genome and Epidemiology Study

Kityo, A., & Lee, S. (2024) · Journal of Epidemiology and Global Health · doi:10.1007/s44197-024-00282-w · Cited by 18

Insulin resistance: Risk factors, diagnostic approaches and mathematical models for clinical practice, epidemiological studies, and beyond

Krzymień, J., & Ładyżyński, P. (2023) · Journal of Applied Biomedicine · doi:10.1016/j.bbe.2023.12.004 · Cited by 20

Impact of high body mass index on gallbladder and biliary tract cancer burden in China: a comprehensive analysis of trends from 1990 to 2021

Zhan, Z., Chen, X., Xu, S., Li, Q., Yu, J., Guo, Z., & Chen, B. (2024) · World Journal of Surgical Oncology · doi:10.1186/s12957-024-03582-4 · Cited by 17

Metabolic and Genetic Association of Vitamin D with Calcium Signaling and Insulin Resistance

Tarfeen, N., Nisa, K. U., Ahmad, M. B., Waza, A. A., & Ganai, B. A. (2022) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-022-01105-0 · Cited by 19

MultiCens: Multilayer network centrality measures to uncover molecular mediators of tissue-tissue communication

Kumar, T., Sethuraman, R., Mitra, S., Ravindran, B., & Narayanan, M. (2023) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1011022 · Cited by 18

Probing the diabetes and colorectal cancer relationship using gene – environment interaction analyses

Dimou, N. L., Kim, A. E., Flanagan, O., Murphy, N., Díez‐Obrero, V., Shcherbina, A., Aglago, E. K., Bouras, E., Campbell, P. T., Casey, G., et al. (2023) · British Journal of Cancer · doi:10.1038/s41416-023-02312-z · Cited by 16

Neddylation of insulin receptor substrate acts as a bona fide regulator of insulin signaling and its implications for cancer cell migration

Park, J. B., Moon, G. H., Cho, A., Kwon, M., Park, J., Yi, E. C., Kim, H., Fukuda, J., Kwak, C. H., Ko, Y., et al. (2024) · Cancer Gene Therapy · doi:10.1038/s41417-024-00729-z · Cited by 16

Metabolic dysfunction-associated steatotic liver disease and urinary system cancers: Mere coincidence or reason for concern?

Bril, F., & Elbert, A. E. (2024) · Metabolism · doi:10.1016/j.metabol.2024.156066 · Cited by 17

Diabetes mellitus in relation to colorectal tumor molecular subtypes: A pooled analysis of more than 9000 cases

Harlid, S., Guelpen, B. R. V., Qu, C., Gylling, B., Aglago, E. K., Amitay, E. L., Brenner, H., Buchanan, D. D., Campbell, P. T., Cao, Y., et al. (2022) · International Journal of Cancer · doi:10.1002/ijc.34015 · Cited by 15

Obesity and Cancer Risk in White and Black Adults: A Prospective Cohort Study

Brown, J. C., Yang, S., Mire, E. F., Wu, X., Miele, L., Ochoa, A. C., Zabaleta, J., & Katzmarzyk, P. T. (2021) · Obesity · doi:10.1002/oby.23163 · Cited by 14

mTORC1 syndrome (TorS): unified paradigm for diabetes/metabolic syndrome

Bar‐Tana, J. (2023) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2023.01.001 · Cited by 16

Interlinking of diabetes mellitus and cancer: An overview

Ahmad, I., Suhail, M., Ahmad, A., Alhosin, M., & Tabrez, S. S. M. (2023) · Cell Biochemistry and Function · doi:10.1002/cbf.3802 · Cited by 14

Complexity of insulin resistance in early-onset colorectal cancer

Samuel, S. M., Varghese, E., & Büsselberg, D. (2025) · Cancer Cell · doi:10.1016/j.ccell.2025.03.033 · Cited by 13

A prospective investigation of early-onset colorectal cancer risk factors–pooled analysis of three large-scale European cohorts

Laskar, R. S., Murphy, N., Ferrari, P., Brennan, P., Cross, A. J., Guevara, M., Pala, V. M., Smith-Byrne, K., Tjønneland, A. M., Fortner, R. T., et al. (2025) · British Journal of Cancer · doi:10.1038/s41416-025-03303-y · Cited by 13

Glucagon-like peptide 1 receptor agonists and cancer risk: the good, the bad and the unknown

Mannucci, E., & Dicembrini, I. (2026) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-026-01135-0 · Cited by 14

Advancements in the study of glucose metabolism in relation to tumor progression and treatment

Zhao, M., Chen, Y., & Yang, L. (2024) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2024.08.001 · Cited by 13

New Discoveries and Ambiguities of Nrf2 and ATF3 Signaling in Environmental Arsenic-Induced Carcinogenesis

Bi, Z., Fu, Y. S., Wadgaonkar, P., Qiu, Y., Almutairy, B. S., Zhang, W., Seno, A., Thakur, C., & Chen, F. (2021) · Antioxidants · doi:10.3390/antiox11010077 · Cited by 13

Metabolic syndrome in colorectal cancer liver metastasis: metabolic reprogramming and microenvironment crosstalk

Ma, Z., Wang, S., Liu, S., Yang, W., Hu, J., Lv, L., Qian, Y., & Lu, Y. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1653442 · Cited by 17

Multivariate genome-wide analyses of insulin resistance unravel novel loci and therapeutic targets for cardiometabolic health

Ye, C., Dou, C., Liu, D., Kong, L., Chen, M., Xu, M., Xu, Y., Li, M., Zhao, Z., Zheng, J., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-64985-9 · Cited by 13

Association of Measures of Glucose Metabolism with Colorectal Cancer Risk in Older Chinese: A 13-Year Follow-up of the Guangzhou Biobank Cohort Study-Cardiovascular Disease Substudy and Meta-Analysis

Wang, S., Zhang, W. S., Jiang, C. Q., Jin, Y. L., Zhu, T., Zhu, F., & Xu, L. (2024) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2022.0383 · Cited by 12

Exercise as a therapeutic intervention for long-lasting and chronic diseases

Febbraio, M. A., & Pedersen, B. K. (2026) · Cell Metabolism · doi:10.1016/j.cmet.2026.02.017 · Cited by 12

Diabetes Mellitus and Gastric Cancer: Correlation and Potential Mechanisms

Wang, L., & Zhang, Z. (2023) · Journal of Diabetes Research · doi:10.1155/2023/4388437 · Cited by 11

Cancer screening in patients with acromegaly: a plea for a personalized approach and international registries

Demarchis, L., Chiloiro, S., Giampietro, A., Marinis, L. D., Bianchi, A., Fleseriu, M., & Pontecorvi, A. (2025) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-025-09957-6 · Cited by 11

Lessons to Learn for Adequate Targeted Therapy Development in Metastatic Colorectal Cancer Patients

Oliveres, H., Pesántez, D., & Maurel, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22095019 · Cited by 11

Insulin Analogues with Altered Insulin Receptor Isoform Binding Specificities and Enhanced Aggregation Stabilities

Páníková, T., Mitrová, K., Halamová, T., Mrzílková, K., Pícha, J., Chrudinová, M., Kurochka, A. S., Selicharová, I., Žáková, L., & Jiráček, J. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c01388 · Cited by 11

Genetically proxied impaired GIPR signaling and risk of 6 cancers

Rogers, M., Gill, D., Ahlqvist, E., Robinson, T., Mariosa, D., Johansson, M., Penha, R. C. C., Dossus, L., Gunter, M. J., Moreno, V. R., et al. (2023) · iScience · doi:10.1016/j.isci.2023.106848 · Cited by 10

Metabolic intervention by low carbohydrate diet suppresses the onset and progression of neuroendocrine tumors

Chen, Y., Yamamoto, T., Takahashi, Y., Moro, T., Tajima, T., Sakaguchi, Y., Sakata, N., Yokoyama, A., Hijioka, S., Sada, A., et al. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-06123-1 · Cited by 13

Mechanisms Underlying the Rarity of Skeletal Muscle Cancers

Kump, D. S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25126480 · Cited by 10

Pathological Significance of GLUT-1 Expression in Breast Cancer Cells in Diabetic and Obese Patients: The French Guiana Study

Suteau, V., Bukasa-Kakamba, J., Cenciu, B., Adenis, A. A., Sabbah, N., & Alsibai, K. D. (2022) · Cancers · doi:10.3390/cancers14020437 · Cited by 10

The Impact of Bariatric Surgery on Pancreatic Cancer Risk: a Systematic Review and Meta-Analysis

Fan, H.-D., Mao, Q., Zhang, W., Fang, Q., Zou, Q., & Gong, J. (2023) · Obesity Surgery · doi:10.1007/s11695-023-06570-x · Cited by 10

Insulin resistance: mechanisms and therapeutic interventions

Yu, L., Qian, J., Li, X., Tian, M., Bai, X., Yang, J., Deng, R., Lu, C., He, X., Lü, A., et al. (2026) · Molecular Biomedicine · doi:10.1186/s43556-026-00408-5 · Cited by 12

Dietary Acid Load and Cancer Risk: A Review of the Uruguayan Experience

Ronco, Á. L., & Storz, M. A. (2023) · Nutrients · doi:10.3390/nu15143098 · Cited by 12

Insulin resistance and hyperinsulinaemia in the development and progression of cancer

Godsland, I. F. (2009) · Clinical Science · doi:10.1042/cs20090399 · Cited by 233

Hyperinsulinaemia and cancer risk: cause and effect?

Kilvert, A., & Fox, C. (2020) · Practical Diabetes · doi:10.1002/pdi.2310 · Cited by 10

Insulin Resistance: The Increased Risk of Cancers

Szablewski, L. (2024) · Current Oncology · doi:10.3390/curroncol31020075 · Cited by 123

A Twenty-First Century Cancer Epidemic Caused by Obesity: The Involvement of Insulin, Diabetes, and Insulin-Like Growth Factors

Westley, R., & May, F. E. B. (2013) · International Journal of Endocrinology · doi:10.1155/2013/632461 · Cited by 60

Rethinking the Relationship between Insulin and Cancer

Vigneri, R., Sciacca, L., & Vigneri, P. G. (2020) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2020.05.004 · Cited by 90